- Home
- TBBK vs PCVX Comparison
TBBK vs PCVX Comparison
Compare TBBK & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBBK
- PCVX
- Stock Information
- Founded
- TBBK 1999
- PCVX 2013
- Country
- TBBK United States
- PCVX United States
- Employees
- TBBK N/A
- PCVX N/A
- Industry
- TBBK Major Banks
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- TBBK Finance
- PCVX Health Care
- Exchange
- TBBK Nasdaq
- PCVX Nasdaq
- Market Cap
- TBBK 3.5B
- PCVX 4.0B
- IPO Year
- TBBK 2004
- PCVX 2020
- Fundamental
- Price
- TBBK $76.28
- PCVX $32.34
- Analyst Decision
- TBBK Buy
- PCVX Strong Buy
- Analyst Count
- TBBK 4
- PCVX 8
- Target Price
- TBBK $68.00
- PCVX $135.00
- AVG Volume (30 Days)
- TBBK 614.4K
- PCVX 1.4M
- Earning Date
- TBBK 10-23-2025
- PCVX 11-04-2025
- Dividend Yield
- TBBK N/A
- PCVX N/A
- EPS Growth
- TBBK 21.62
- PCVX N/A
- EPS
- TBBK 4.65
- PCVX N/A
- Revenue
- TBBK $515,889,000.00
- PCVX N/A
- Revenue This Year
- TBBK N/A
- PCVX N/A
- Revenue Next Year
- TBBK $7.02
- PCVX N/A
- P/E Ratio
- TBBK $16.35
- PCVX N/A
- Revenue Growth
- TBBK 11.18
- PCVX N/A
- 52 Week Low
- TBBK $40.51
- PCVX $27.66
- 52 Week High
- TBBK $80.16
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- TBBK 67.31
- PCVX 50.16
- Support Level
- TBBK $75.00
- PCVX $31.47
- Resistance Level
- TBBK $77.25
- PCVX $33.32
- Average True Range (ATR)
- TBBK 2.14
- PCVX 1.27
- MACD
- TBBK -0.17
- PCVX 0.24
- Stochastic Oscillator
- TBBK 56.13
- PCVX 62.89
About TBBK The Bancorp Inc
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.